Yubo International Biotech annual ebitda
2020
2021
2022
2023
2024
2025
Yubo International Biotech EBITDA Growth & History (YBGJ)
Yubo International Biotech's calculated EBITDA was −$1.0M for fiscal 2025.
View full Yubo International Biotech company overviewYubo International Biotech annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$1.0M | $579,929 | — |
| 2024 | 2024-12-31 | −$1.6M | −$583,650 | — |
| 2023 | 2023-12-31 | −$1.0M | $170,731 | — |
| 2022 | 2022-12-31 | −$1.2M | $342,518 | — |
| 2021 | 2021-12-31 | −$1.5M | −$830,908 | — |
| 2020 · Dec 31 | 2020-12-31 | −$698,735 | — | — |
Yubo International Biotech quarterly ebitda
Q1.20
Q1.21
Q2.21
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$238,067 | −$30,112 | — |
| Q1 2026 | 2026-03-31 | −$263,529 | $162,147 | — |
| Q4 2025 | 2025-12-31 | −$118,243 | $199,887 | — |
| Q3 2025 | 2025-09-30 | −$268,241 | $218,528 | — |
| Q2 2025 | 2025-06-30 | −$207,955 | $221,073 | — |
| Q1 2025 | 2025-03-31 | −$425,676 | −$59,559 | — |
| Q4 2024 | 2024-12-31 | −$318,130 | $87,188 | — |
| Q3 2024 | 2024-09-30 | −$486,769 | −$537,398 | — |
| Q2 2024 | 2024-06-30 | −$429,028 | −$77,264 | — |
| Q1 2024 | 2024-03-31 | −$366,117 | −$56,176 | — |
| Q4 2023 | 2023-12-31 | −$405,318 | −$510,759 | — |
| Q3 2023 | 2023-09-30 | $50,629 | $283,623 | — |
| Q2 2023 | 2023-06-30 | −$351,764 | $134,452 | — |
| Q1 2023 | 2023-03-31 | −$309,941 | $263,415 | — |
| Q4 2022 | 2022-12-31 | $105,441 | $496,007 | — |
| Q3 2022 | 2022-09-30 | −$232,994 | $107,968 | — |
| Q2 2022 | 2022-06-30 | −$486,216 | −$121,745 | — |
| Q1 2022 | 2022-03-31 | −$573,356 | −$139,712 | — |
| Q4 2021 | 2021-12-31 | −$390,566 | −$100,259 | — |
| Q3 2021 · Sep 30 | 2021-09-30 | −$340,962 | −$311,077 | — |
| Q2 2021 · Jun 30 | 2021-06-30 | −$364,471 | −$225,393 | — |
| Q1 2021 · Mar 31 | 2021-03-31 | −$433,644 | — | — |
| Q2 2021 · Sep 30 | 2020-09-30 | −$290,307 | — | — |
| Q1 2021 · Jun 30 | 2020-06-30 | −$29,885 | — | — |
| Q1 2020 · Mar 31 | 2020-03-31 | −$139,078 | — | — |
Yubo International Biotech ebitda trends
Over the last five reported fiscal years, Yubo International Biotech's ebitda decreased from −$698,735 to −$1.0M, a change of −$321,380. The latest reported quarter, Q2 2026, shows −$238,067.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yubo International Biotech filings at SEC.gov ↗